Geode Capital Management’s Generation Bio GBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-51,795
Closed -$294K 4553
2025
Q4
$294K Buy
51,795
+1,990
+4% +$11.2K ﹤0.01% 3778
2025
Q3
$305K Sell
49,805
-3
-0% -$16 ﹤0.01% 3791
2025
Q2
$159K Sell
49,808
-61,034
-55% -$235K ﹤0.01% 3946
2025
Q1
$449K Sell
110,842
-2,866
-3% -$20.1K ﹤0.01% 3582
2024
Q4
$1.21M Sell
113,708
-209
-0.2% -$3.73K ﹤0.01% 3298
2024
Q3
$2.81M Buy
113,917
+326
+0.3% +$8.62K ﹤0.01% 3019
2024
Q2
$3.2M Buy
113,591
+6,522
+6% +$212K ﹤0.01% 2953
2024
Q1
$4.36M Sell
107,069
-727
-0.7% -$17.1K ﹤0.01% 2768
2023
Q4
$1.78M Buy
107,796
+6,619
+7% +$115K ﹤0.01% 3148
2023
Q3
$3.84M Buy
101,177
+707
+0.7% +$33.5K ﹤0.01% 2772
2023
Q2
$5.53M Buy
100,470
+7,094
+8% +$326K ﹤0.01% 2624
2023
Q1
$4.02M Buy
93,376
+6,526
+8% +$316K ﹤0.01% 2735
2022
Q4
$3.41M Buy
86,850
+1,357
+2% +$71.3K ﹤0.01% 2851
2022
Q3
$4.54M Buy
85,493
+3,443
+4% +$215K ﹤0.01% 2732
2022
Q2
$5.38M Buy
82,050
+2,746
+3% +$180K ﹤0.01% 2663
2022
Q1
$5.82M Buy
79,304
+4,382
+6% +$254K ﹤0.01% 2710
2021
Q4
$5.3M Sell
74,922
-3,742
-5% -$653K ﹤0.01% 2866
2021
Q3
$19.7M Buy
78,664
+22,377
+40% +$5.36M ﹤0.01% 1967
2021
Q2
$15.1M Buy
56,287
+3,972
+8% +$1.19M ﹤0.01% 2163
2021
Q1
$14.9M Buy
52,315
+29,756
+132% +$9.52M ﹤0.01% 2072
2020
Q4
$6.39M Buy
22,559
+2,335
+12% +$749K ﹤0.01% 2467
2020
Q3
$6.25M Buy
20,224
+17,786
+730% +$4.25M ﹤0.01% 2264
2020
Q2
$512K Buy
+2,438
New +$543K ﹤0.01% 3368

Other funds holding GBIO

Geode Capital Management's GBIO Position: Q1 2026 in Review

Geode Capital Management sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 51,795 shares — an estimated $294K sold.

Geode Capital Management first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $19.7M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

  • Geode Capital Management reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 51,795 Generation Bio shares in Q1 2026, an estimated $294K.
  • Geode Capital Management first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
  • Geode Capital Management's Generation Bio position peaked at $19.7M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.